Hana Biosciences to Present At the Canaccord Adams 28th Annual Global Growth Conference
SOUTH SAN FRANCISCO, Calif., Aug. 7, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, today announced that Steven R. Deitcher, M.D., President & Chief Executive Officer, will present a company update at the Canaccord Adams 28th Annual Global Growth Conference on Thursday, August 14, 2008 at 10:00 a.m. ET at the InterContinental Hotel in Boston, MA.
The presentation will be webcast live and archived on the company's website, www.hanabiosciences.com.
About Hana Biosciences, Inc.
Hana Biosciences, Inc. (Nasdaq:HNAB) is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care. The company is committed to creating value by building a best-in-class team, accelerating the development of lead product candidates, expanding its pipeline by being an alliance partner of choice, and nurturing a unique company culture. Further information on Hana Biosciences can be found at www.hanabiosciences.com.
The Hana Biosciences, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3290
Investor & Media Contacts:
Remy Bernarda, Director, Investor Relations
Fax (650) 588-2787